Wound Care Biologics Market Industry Share, Size: 2022 Market Research with Growth, Manufacturers, Segments and Forecast – 2028

The global wound care biologics market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The healing of wounds is a complicated process that involves the synchronizing and activating of various intracellular, extracellular as well as intercellular elements, which includes coagulatory and deposition of collagen, epithelialization, fibrous tissue accretion, wound contraction, inflammatory events, tissue granulation, and remodeling. Wound care biologics are gaining popularity for the treatment of wounds and burn injuries. Biological wound healing therapies are intended to facilitate the re-establishment of natural repair. The growing burden of burn injuries, the increasing burden of diabetic foot ulcers, and government initiatives regarding wound care treatment are some factors that are driving the growth of the wound care biologics market.

A significant increase in the utilization of temporary and permanent skin substitutes, growing demand for combination dressings, rising focus of biotechnological and pharmaceutical companies on new biologics are the key trends observed in the wound care biologics market. Increasing interest in biologics is resulting in the upgrading of new and improved products that are used by wound care specialists for the treatment of acute and chronic wounds which include diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), pressure ulcers, and surgical and burn injuries.

Scope of the Wound Care Biologics Report

The research study analyzes the Wound Care Biologics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis

o Import and Export Overview

o Volume Analysis

o Current Market Trends and Future Outlook

o Market Opportunistic and Attractive Investment Segment

Market Segmentation:

By Product

• Biologic Skin Substitute
• Topical Agent

By Wound Type

• Ulcers
• Surgical and Traumatic Wounds

By End-User

• Hospitals
• Burn Centre
• Homecare

Wound Care Biologics Market Segmentation:

Some major players in the market include Johnson & Johnson Services, Inc., Smith & Nephew PLC, and Integra LifeSciences, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in June 2019, Smith & Nephew plc introduced the new PICO 14 which is a single-use negative-pressure wound therapy system, with a pump duration of up to 14 days. This enhanced pump aids its use in large and deep wounds, with reduced user intervention. Additionally, in January 2019, Generex Biotechnology Corporation and Collagen Solutions plc, which is a supplier of medical-grade collagen biomaterials that are used for research purposes, medical devices, and regenerative medicine applications. Both the companies have signed a manufacturing agreement to produce and package Excellagen.

Geographic Coverage

o North America Market Size and/or Volume

o Latin America Market Size and/or Volume

o Europe Market Size and/or Volume

o Asia-Pacific Market Size and/or Volume

o Rest of the world Market Size and/or Volume

Key Questions Answered by Wound Care Biologics Market Report

1. What was the Wound Care Biologics Market size in 2021 and 2027; what are the estimated growth trends and market forecast (2022-2028).
2. What will be the CAGR of Wound Care Biologics Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Wound Care Biologics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

The report covers the following objectives:

• Proliferation and maturation of trade in the Wound Care Biologics market.
• The market share of the Wound Care Biologics market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the Wound Care Biologics market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the Wound Care Biologics market.